Published in J Pediatr on May 01, 1991
Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr (2012) 1.55
Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol (2009) 1.46
Kawasaki disease in Australia, 1993-95. Arch Dis Child (1998) 1.42
Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr (2008) 1.32
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity (2010) 1.12
Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol Med (2012) 1.05
Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J (2011) 1.03
Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J (2011) 1.03
Abnormal liver panel in acute kawasaki disease. Pediatr Infect Dis J (2011) 1.02
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis (2009) 0.99
Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. J Pediatr (2013) 0.99
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report. Pediatr Rheumatol Online J (2014) 0.95
Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci (2008) 0.90
Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open (2015) 0.87
Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease. Pediatr Cardiol (2014) 0.85
An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study. Clinics (Sao Paulo) (2010) 0.81
Kawasaki disease--a diagnostic challenge. Br J Gen Pract (1999) 0.80
Kawasaki disease in infants. Korean J Pediatr (2013) 0.79
Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care. Br J Gen Pract (1999) 0.78
Unilateral cervical mass as a main clue raising the diagnostic suspicion of Kawasaki syndrome. Rheumatol Int (2007) 0.77
Infliximab treatment of pancreatitis complicating acute kawasaki disease. Pediatr Infect Dis J (2012) 0.76
Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy. Korean J Pediatr (2016) 0.75
Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus. Paediatr Child Health (2001) 0.75
Perioperative considerations of kawasaki disease. Ochsner J (2013) 0.75
A four-time-recurring typical complete Kawasaki syndrome successfully treated with intravenous immunoglobulin: a case report with literature review. Rheumatol Int (2012) 0.75
Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet (1975) 6.25
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
The staphylococcal scalded-skin syndrome. N Engl J Med (1970) 5.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med (1998) 3.95
Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation (1995) 3.80
The relationship between managed care insurance and use of lower-mortality hospitals for CABG surgery. JAMA (2000) 3.75
The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J Infect Dis (1972) 3.45
Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest (1995) 3.36
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) 3.04
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet (1989) 2.86
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr (1996) 2.77
Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg (2001) 2.70
Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67
Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation (1999) 2.67
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics (1995) 2.60
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J (1998) 2.53
Mucocutaneous lymph node syndrome in the United States. Am J Dis Child (1976) 2.52
Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39
Noninvasive tests in the initial evaluation of heart murmurs in children. N Engl J Med (1983) 2.39
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13
Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Pediatr (1971) 2.11
Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis (1989) 2.09
Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Lancet (1981) 1.99
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res (1976) 1.96
A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol (1998) 1.91
Viral infections in interferon-gamma receptor deficiency. J Pediatr (1999) 1.91
The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol (2006) 1.86
Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr (1998) 1.84
Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis (1977) 1.84
Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology (2012) 1.81
Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg (1997) 1.75
Abandoning empirical antibiotics for febrile children. Lancet (1997) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
Action potential in the transverse tubules and its role in the activation of skeletal muscle. J Gen Physiol (1974) 1.74
Kawasaki disease in infants less than one year of age. J Pediatr (1995) 1.67
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr (1997) 1.64
Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol (1999) 1.64
Monocular acuity norms for the Teller Acuity Cards between ages one month and four years. Invest Ophthalmol Vis Sci (1995) 1.64
Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation (1997) 1.63
CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis (2001) 1.62
Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics (1999) 1.61
Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA (1997) 1.61
Cognitive development after the Fontan operation. Circulation (2000) 1.60
Congenital cytomegalovirus infection. Developmental progress of infants detected by routine screening. Am J Dis Child (1973) 1.60
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis (2000) 1.58
Clinical aspects of acute rheumatic fever. J Rheumatol Suppl (1991) 1.57
Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. N Engl J Med (1992) 1.57
Kawasaki syndrome. Rev Infect Dis (1988) 1.55
Kawasaki syndrome. Pediatr Clin North Am (1999) 1.53
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr (1988) 1.49
Evaluation of an ELISA for group A streptococcal antigen for diagnosis of pharyngitis. J Pediatr (1987) 1.47
Incomplete Kawasaki disease with coronary artery involvement. J Pediatr (1987) 1.46
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology (2008) 1.45
Gowning does not affect colonization or infection rates in a neonatal intensive care unit. Arch Pediatr Adolesc Med (1994) 1.45
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol (1997) 1.44
The infant rat as a model of bacterial meningitis. J Infect Dis (1977) 1.44
An outbreak of Hemophilus influenzae type b meningitis in an enclosed hospital population. J Pediatr (1976) 1.44
Spectrum of renal anomalies in patients with Williams syndrome. J Pediatr (1991) 1.43
Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg (1997) 1.41
Hyperlipidemia in children and adolescents. Am Heart J (2001) 1.41
Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation (1994) 1.39
Kawasaki syndrome (the mucocutaneous lymph node syndrome). Pediatr Ann (1982) 1.38
Familial aggregation of stroke. The Framingham Study. Stroke (1993) 1.36
Systemic candidiasis in infants: a case presentation and literature review. Am J Dis Child (1977) 1.35
Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. J Infect Dis (1979) 1.35
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Physical activity and stroke risk: the Framingham Study. Am J Epidemiol (1994) 1.33